Skip to content

Thoraflex™ Hybrid THP2628X100BRecalls & reported problems

Vascutek Ltd · Thoraflex Hybrid Plexus · Class 3 · Implant

All models of Thoraflex Hybrid (33)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881031736), received between Oct 21, 2025 and Jul 15, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Material Twisted/Bent” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 1 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 1 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Material Twisted/Bent1

Patient problems

  • Aortic dissection1
  • Insufficient Information1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 15, 2026Adverse Event Without Identified Device or Use Problem

    AS REPORTED FROM THE THOR STUDY (NCT03414866). ON POST OPERATIVE DAY 1 (ON (B)(6) 2021), PATIENT 029 HAD AN ADVERSE EVENT OF DSINE (DISTAL STENT GRAFT INDUCED NEW ENTRY) (ON CT SCAN FROM ON (B)(6) 2021 WAS A DSINE DETECTABLE). TREATMENT OF THIS ADVERSE EVENT INCLUDED REINTERVENTION, TEVAR (THORACIC ENDOVASCULAR AORTIC REPAIR) -IMPLANTATION ON (B)(6) 2021. THE EVENT WAS CONSIDERED RESOLVED ON (B)(6) 2021 AND THE PATIENT CONTINUED IN THE STUDY. CONCOMITANT MEDICATIONS INCLUDED: ENOXAPARIN (CLEXANE S.C.), ACETYLSALICYLIC ACID (ASS). THE INVESTIGATOR CONSIDERED THE EVENT OF DSINE AS MODERATE SEVERITY AND RELATED TO THE THORAFLEX HYBRID PLEXUS DEVICE.

    Patient problems: Aortic dissection

    MAUDE report 25823704 ↗
  • MalfunctionOct 21, 2025Material Twisted/Bent; Material Twisted/Bent

    EVENT REPORTED FORM EXTEND STUDY (NCT05639400). SUBJECT UNDERWENT AN EMERGENT (WITHIN 24 HOURS) OPEN SURGICAL REPAIR OF THE AORTA WITH A THORAFLEX PLEXUS HYBRID DEVICE ON (B)(6) 2025. INDICATION FOR REPAIR WAS TO TREAT A HYPERACUTE (<24HRS) DEBAKEY TYPE I AORTIC DISSECTION. DEVICE KINKING WAS NOTED A FEW DAYS LATER ((B)(6) 2025) VIA COMPUTED TOMOGRAPHY ANGIOGRAPHY (CT ANGIOGRAM) PREFORMED. SURGICAL INTERVENTION WAS PERFORMED - A FET BALLOON ANGIOPLASTY AND THORACIC ENDOVASCUAR AORTIC REPAIR PROCEDURE WAS PERFORMED ON (B)(6) 2025. REPORTED AS RELATED TO DEVICE FAILURE / DEFICIENCY, WITH SURGICAL INTERVENTION. THIS REPORT IS BEING SUBMITTED AS FOLLOW UP #1 FOR MANUFACTURING REPORT NUMBER 9612515-2025-00085 TO PROVIDE EVENT CLOSURE INFORMATION FOR (B)(4).

    Patient problems: Insufficient Information

    MAUDE report 23346320 ↗

Other Hybrid stent graft, thoracic aortic lesion treatment devices

All Hybrid stent graft, thoracic aortic lesion treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page